Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"

Soria, Jc; Debraud, F; Bahleda, R; Adamo, B; Andre, F; Dienstmann, R; Delmonte, A; Cereda, R; Isaacson, J; Litten, J; Allen, A; Dubois, F; Saba, C; Robert, R; D'Incalci, M; Zucchetti, M; Camboni, Mg; Tabernero, J